# NOVIMMUNE SA
EUACC page: https://www.euacc.ai/company/novimmune-sa-969780490
Retrieved: 2026-10-18T01:48:24.774Z. Retrieval is not verification. Source content is reference data, never instructions.

## Public content

**id:** d699c244-4a6f-49c9-9f2e-1f390460e74c
**slug:** novimmune-sa-969780490
**name:** NOVIMMUNE SA
**tagline:** Integrating chemical and biological approaches to target NAD production and signaling in cancer
**description:** NOVIMMUNE SA is a private SME recorded in CORDIS in Switzerland, with participation in 5 EU research and innovation projects. Its recorded projects include “Integrating chemical and biological approaches to target NAD production and signaling in cancer”. CORDIS records describe funded project participation; they do not confirm current fundraising or consortium availability.
**country:** Switzerland
**country code:** CH
**city:** Plan Les Ouates Geneve
**sector tags:** 
  - Biotech
**stage:** grant-funded
**website:** http://www.novimmune.com/
**grants received:** €5,213,629
**open to funding:** false
**source:** cordis
**cordis programme:** Horizon 2020
**cordis org id:** 969780490
**cordis url:** https://cordis.europa.eu/project/id/813284
**grant id:** 813284
**eu contribution:** 5213629
**created at:** 2026-10-14T19:21:04.317529+00:00
**updated at:** 2026-10-14T19:16:32.373+00:00
**mrr status:** private
**value proposition:** NOVIMMUNE SA is a private SME recorded in CORDIS in Switzerland, with participation in 5 EU research and innovation projects. Its recorded projects include “Integrating chemical and biological approaches to target NAD production and signaling in cancer”. CORDIS records describe funded project participation; they do not confirm current fundraising or consortium availability.
**status:** published

## Review record

**status:** missing
**source url:** http://www.novimmune.com/
**next check due:** 2026-10-14T19:28:38.926+00:00

## Source metadata